Helge Jörn Zöllner1,2, Markus Butz1, Gerald Kircheis3, Stefan Klinker4, Dieter Häussinger3, Benjamin Schmitt5, Alfons Schnitzler1, and Hans-Jörg Wittsack2
1Institute of Clincial Neuroscience and Medical Psychology, Heinrich Heine University, Düsseldorf, Germany, 2Department of Diagnostic and Interventional Radiology, Heinrich Heine University, Düsseldorf, Germany, 3Department of Gastroenterology, Hepatology and Infectiology, Heinrich Heine University, Düsseldorf, Germany, 4Institute of Physical Biology, Heinrich Heine University, Düsseldorf, Germany, 5160 Herring Road, Siemens Healthcare Pty Ltd., Macquarie Park NSW 2113, Australia
Synopsis
Chemical exchange saturation transfer (CEST) is an advanced
MR contrast, which is sensitive to metabolic parameters as pH or protein
content. The present study shows the ammonia-sensitivity of amide proton CEST
imaging at a fixed pH value. The in vivo
applicability is tested in a population of patients suffering from hepatic
encephalopathy (HE), which is linked to ammonia accumulation within the brain. In
HE, the CEST signal is especially reduced within occipital and cerebral regions.
This reduction may be related to increased ammonia levels in HE patients.
Introduction
Hepatic
encephalopathy (HE) is a common complication in patients with liver cirrhosis.
It comprises a variety of neuropsychiatric and motor symptoms1 and leads to an increase of
ammonia within the brain2. Therefore, it is desirable
to create 3D metabolic images of the whole brain to reflect the content of
ammonia non-invasively. The present study tests the feasibility of chemical
exchange saturation transfer imaging (CEST) to display changes in protein CEST signal
depending on the content of ammonia.Methods
In vivo acquisition was performed on a clinical 3 T whole-body MRI scanner (Siemens
MAGNETOM Trio A TIM System, Siemens Healthcare GmbH, Erlangen, Germany) using a
12-channel head matrix coil. A prototype 3D gradient echo sequence (echo time TE=3.06ms;
repetition time TR=1390ms; FA=10°; FoV=(230x230)mm2; 24 slices; 5mm slice
thickness; 1mm gap) with a pre-saturation block (5 gaussian shaped pulses;
pulse duration PD=100ms; inter pulse delay IPD=100ms; 22 equidistant frequency
offsets between ±5ppm; B1=1.5µT; 3s break) was used for in vivo CEST imaging and B0 correction via WASSR3 (changed parameters: 1
gaussian shaped pulse; PD=5ms; IPD=6ms; equidistant offset ±1ppm; B1=0.3µT). B1
correction was performed using a one-point correction method4 with a relative B1 map5. In vitro measurements were performed within the steady state, using
48 gaussian shaped pulses at 44 equidistant frequency offsets between ±5ppm. In
addition, nine different B1
amplitudes (B1 = 0.4, 0.7, 1, 1.3, 1.4, 1.5, 1.6, 1.7, 2 µT) were
used for B1 correction4.
We evaluated
our approach in a two-step procedure: First, bovine serum albumin (BSA)
solutions (2.5%) and brain samples consisting of one part of diluted and
homogenized pig brain tissue (tissue:water ≡ 1:2) and two parts of buffered
ammonia solutions at fixed pH=7 were tested with varying ammonia concentrations
([0, 0.5, 5, 50, 500] µM, [5,
50, 500] mM). Fluorescence spectroscopy was used to determine possible changes
in protein folding in the BSA phantom.
In a second
step, 32 participants (11 female; mean age ± standard deviation: 58 ± 6.6
years) were examined after written informed consent, including 14 healthy
control, 7 minimal HE (mHE), and 9 HE I patients, graded according to the
West-Haven criteria. Anatomical imaging for segmentation purpose and relative
B1 correction4 were performed. Post processing was realised with an
in-house written MATLAB script (MathWorks Inc, Natrick, MA, USA). All images were
smoothed by Gaussian kernel and normalized to S0. Interpolation of CEST and
WASSR z-spectra was done with MATLAB interp1 algorithm (step size of h=0.001).
CEST z-spectra were shifted by the calculated WASSR offset to reduce B0
inhomogeneity effects. The magnetization transfer ratio asymmetry (MTRasym) was
determined for amide protons around (3.5 ± 0.5) ppm. The in vivo measurements were coregistered onto the first offset image
(S0) with SPM12 (Wellcome Trust
Centre for Neuroimaging, University College London, UK) to reduce movement
artefacts. In vivo 3D MTRasym maps
were coregistered onto the anatomical images and normalized to MNI-152-space to
create group atlases. MATLAB students’ t-test was used for statistics.Results
In the phantom
measurements the mean MTRasym value decreases significantly with increasing
ammonia concentrations (Figure 1 & Figure 2). No protein unfolding was visible
for concentrations <50 mM (data not shown). Representative slices of the group
MTRasym atlases are depicted in Figure 3, showing that the MTRasym values
within the representative slice of the control, mHE and HE patient decrease with
severity of HE. The mean MTRasym values within the whole cerebellum decreased significantly
from 0.9 ± 1.1
% (control), 0.8 ± 1 % (mHE) to 0.6 ± 0.7 % (HE I).Discussion
The
measurements revealed a significant decrease of the CEST signal with increasing
concentration of ammonia within the phantom. Possible confounders to this
effect are reduction of water T2 values6 due to
ammonia as it is known to suppress MR water signal or small changes in protein
structure7. In the in vivo measurements in patients with HE a decrease in the MTRasym
signal occurred in comparison to healthy controls, which may be due to
ammonia uptake or protein aggregation in astrocytes8.Conclusion
The Chemical
Saturation Transfer (CEST) signal shows an ammonia concentration dependent
contrast, which allows for investigations of patients with hepatic
encephalopathy. Future investigations with larger patient groups should confirm
the current findings and may allow analysing regional alterations within the HE
patient brains.Acknowledgements
This study was supported
by the Sonderforschungsbereich (SFB) 974 (TP B07) of the Deutsche
Forschungsgemeinschaft (DFG).References
-
Häussinger D, Blei AT. Hepatic
encephalopathy. In: Textbook of Hepatology. Wiley-Blackwell Publ.;
2007:728-760.
- Lockwood AH, Yap EW, Wong WH. Cerebral
ammonia metabolism in patients with severe liver disease and minimal hepatic
encephalopathy. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow
Metab. 1991;11(2):337-341. doi:10.1038/jcbfm.1991.67.
- Kim M, Gillen J, Landman BA, Zhou J,
van Zijl PCM. WAter Saturation Shift Referencing (WASSR) for chemical exchange
saturation transfer experiments. Magn Reson Med. 2009;61(6):1441-1450.
doi:10.1002/mrm.21873.
- Windschuh J, Zaiss M, Meissner J-E, et
al. Correction of B1-inhomogeneities for relaxation-compensated CEST imaging at
7 T. NMR Biomed. 2015;28(5):529-537. doi:10.1002/nbm.3283.
- Sabati M, Maudsley AA. Fast and
high-resolution quantitative mapping of tissue water content with full brain
coverage for clinically-driven studies. Magn Reson Imaging.
2013;31(10):1752-1759. doi:10.1016/j.mri.2013.08.001.
- Rabenstein DL, Fan S. Proton nuclear
magnetic resonance spectroscopy of aqueous solutions: complete elimination of
the water resonance by spin-spin relaxation. Anal Chem.
1986;58(14):3178-3184. doi:10.1021/ac00127a057.
- Goerke S, Zaiss M, Kunz P, et al.
Signature of protein unfolding in chemical exchange saturation transfer
imaging. NMR Biomed. 2015;28(7):906-913. doi:10.1002/nbm.3317.
- Norenberg MD. The role of astrocytes
in hepatic encephalopathy. Neurochem Pathol. 1987;6(1-2):13-33.